{"id":17538,"date":"2016-04-21T00:00:00","date_gmt":"2016-04-21T00:00:00","guid":{"rendered":"https:\/\/cadca1stg.wpengine.com\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/"},"modified":"2016-04-21T00:00:00","modified_gmt":"2016-04-21T00:00:00","slug":"critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee","status":"publish","type":"resource","link":"https:\/\/www.cadca.org\/fr\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/","title":{"rendered":"La l\u00e9gislation sur l&#039;abus de substances critiques est adopt\u00e9e par le sous-comit\u00e9 de la sant\u00e9 de la Chambre sur l&#039;\u00e9nergie et le commerce"},"content":{"rendered":"<p>Hier, le sous-comit\u00e9 House Energy &amp; Commerce Health a approuv\u00e9 \u00e0 l&#039;unanimit\u00e9 12 initiatives l\u00e9gislatives bipartites visant \u00e0 lutter contre les probl\u00e8mes d&#039;abus d&#039;opio\u00efdes et de drogues affectant les communaut\u00e9s \u00e0 travers le pays.<\/p>\n<p>HR 3250, The DXM Abuse Prevention Act, r\u00e9dig\u00e9 par le repr\u00e9sentant Bill Johnson (R-Ohio) et la repr\u00e9sentante Doris Matsui (D-Calif.) Est l&#039;un de ces textes l\u00e9gislatifs. Longtemps soutenu par la CADCA, le projet de loi restreindrait la vente de produits contenant du dextrom\u00e9thorphane (DXM) aux adultes de plus de 18 ans dans tout le pays et imposerait des restrictions sur la distribution de DXM en vrac.<\/p>\n<p>Comme d&#039;autres m\u00e9dicaments sur ordonnance et en vente libre, lorsqu&#039;il est utilis\u00e9 correctement, DXM est totalement s\u00fbr. Cependant, ces derni\u00e8res ann\u00e9es, un sous-ensemble d&#039;adolescents a abus\u00e9 de cette drogue. Lorsqu&#039;il est ing\u00e9r\u00e9 \u00e0 fortes doses, les effets secondaires peuvent inclure de la confusion, des \u00e9tourdissements, une vision double ou floue, des troubles de l&#039;\u00e9locution, une perte de coordination physique, des vomissements, un rythme cardiaque rapide et, dans certains cas, des d\u00e9c\u00e8s involontaires.<\/p>\n<p>Les restrictions d&#039;\u00e2ge constituent un moyen efficace de limiter l&#039;acc\u00e8s \u00e0 la petite population d&#039;adolescents susceptibles d&#039;abuser des m\u00e9dicaments contre la toux. La CADCA et ses 5 000 membres \u00e0 l&#039;\u00e9chelle nationale saluent les efforts du sous-comit\u00e9 pour prot\u00e9ger nos jeunes et faire avancer cette importante l\u00e9gislation.<\/p>\n<p>La CADCA appuie \u00e9galement l&#039;approbation par le sous-comit\u00e9 des textes l\u00e9gislatifs suivants\u00a0:<\/p>\n<ul>\n<li>La loi sur l&#039;expansion et la modernisation du traitement des troubles li\u00e9s \u00e0 l&#039;utilisation d&#039;opio\u00efdes, r\u00e9dig\u00e9e par le repr\u00e9sentant Larry Bucshon, MD (R-Ind.) et le repr\u00e9sentant Paul Tonko (D-NY), qui prend des mesures importantes pour \u00e9largir l&#039;acc\u00e8s au traitement m\u00e9dicamenteux et minimiser le possibilit\u00e9 de d\u00e9tournement de drogue.<br \/>\n\t\u00a0<\/li>\n<li>HR 4586, Lali&#039;s Law, r\u00e9dig\u00e9 par le repr\u00e9sentant Bob Dold (R-Ill.) et la repr\u00e9sentante Katherine Clark (D-Mass.), Qui autorise des subventions aux \u00c9tats pour \u00e9laborer des ordonnances permanentes pour les prescriptions de naloxone tout en \u00e9duquant les professionnels de la sant\u00e9 sur la distribution de m\u00e9dicaments d&#039;inversion de surdosage d&#039;opio\u00efdes.<\/li>\n<\/ul>\n<p>Tous ces efforts sont essentiels pour maintenir des communaut\u00e9s s\u00fbres, saines et sans drogue. \u00c0 une \u00e9poque o\u00f9 notre pays est aux prises avec une \u00e9pid\u00e9mie d\u00e9vastatrice d&#039;opio\u00efdes et d&#039;h\u00e9ro\u00efne, nous devons adopter des solutions concr\u00e8tes pour l&#039;avenir. En 2014, le CDC a signal\u00e9 plus de 47 000 d\u00e9c\u00e8s par surdose, dont plus de 14 000 provenant de m\u00e9dicaments sur ordonnance et plus de 10 500 provenant de l&#039;h\u00e9ro\u00efne. Aujourd&#039;hui plus que jamais, nous devons mettre en \u0153uvre ces propositions. L&#039;ACCCA remercie le sous-comit\u00e9 d&#039;avoir pris des mesures sur ces questions.<\/p>\n<p><strong>VOIR \u00c9GALEMENT:<\/strong><\/p>\n<p><a href=\"https:\/\/www.cadca.org\/fr\/resources\/coalitions-action-pennsylvania-works-remedy-cough-medicine-abuse\/\" target=\"_blank\" rel=\"noopener\">Coalitions en action\u00a0: la Pennsylvanie s&#039;efforce de rem\u00e9dier \u00e0 l&#039;abus des m\u00e9dicaments contre la toux<\/a><\/p>\n<p><a href=\"https:\/\/www.scholastic.com\/OTCmedsafety\/\" target=\"_blank\" rel=\"noopener\">Programme de formation sur la s\u00e9curit\u00e9 des m\u00e9dicaments en vente libre<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Hier, la sous-commission de la sant\u00e9 de la Chambre sur l&#039;\u00e9nergie et le commerce a approuv\u00e9 \u00e0 l&#039;unanimit\u00e9 12 initiatives l\u00e9gislatives bipartites visant \u00e0 lutter contre les opio\u00efdes et les drogues.<\/p>","protected":false},"author":23,"featured_media":0,"template":"","resource_type":[281],"drug_specific_issues":[312,307],"action_to_do":[297],"class_list":["post-17538","resource","type-resource","status-publish","hentry","resource_type-coalitions-online","drug_specific_issues-heroin","drug_specific_issues-prescription-and-over-the-counter-medications","action_to_do-advocate-for-change"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee | CADCA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cadca.org\/fr\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee | CADCA\" \/>\n<meta property=\"og:description\" content=\"Yesterday, the House Energy &#038; Commerce Health Subcommittee unanimously approved 12 bi-partisan legislative initiatives aimed at tackling opioid and drug\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cadca.org\/fr\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/\" \/>\n<meta property=\"og:site_name\" content=\"CADCA\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cadca-member-of-logo1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"880\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\\\/\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\\\/\",\"name\":\"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee | CADCA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\"},\"datePublished\":\"2016-04-21T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cadca.org\\\/resource\\\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cadca.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/\",\"name\":\"CADCA\",\"description\":\"The Premier Prevention Association\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cadca.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee | CADCA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cadca.org\/fr\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/","og_locale":"fr_FR","og_type":"article","og_title":"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee | CADCA","og_description":"Yesterday, the House Energy &#038; Commerce Health Subcommittee unanimously approved 12 bi-partisan legislative initiatives aimed at tackling opioid and drug","og_url":"https:\/\/www.cadca.org\/fr\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/","og_site_name":"CADCA","og_image":[{"width":880,"height":500,"url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cadca-member-of-logo1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cadca.org\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/","url":"https:\/\/www.cadca.org\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/","name":"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee | CADCA","isPartOf":{"@id":"https:\/\/www.cadca.org\/#website"},"datePublished":"2016-04-21T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.cadca.org\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cadca.org\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.cadca.org\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cadca.org\/"},{"@type":"ListItem","position":2,"name":"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee"}]},{"@type":"WebSite","@id":"https:\/\/www.cadca.org\/#website","url":"https:\/\/www.cadca.org\/","name":"CADCA","description":"The Premier Prevention Association","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cadca.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource\/17538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/types\/resource"}],"author":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/users\/23"}],"version-history":[{"count":0,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource\/17538\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/media?parent=17538"}],"wp:term":[{"taxonomy":"resource_type","embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource_type?post=17538"},{"taxonomy":"drug_specific_issues","embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/drug_specific_issues?post=17538"},{"taxonomy":"action_to_do","embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/action_to_do?post=17538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}